McNamara S - Search Results

1

Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis.

Hoffman LR, Pope CE, Hayden HS, Heltshe S, Levy R, McNamara S, Jacobs MA, Rohmer L, Radey M, Ramsey BW, Brittnacher MJ, Borenstein E, Miller SI. Hoffman LR, et al. Among authors: mcnamara s. Clin Infect Dis. 2014 Feb;58(3):396-9. doi: 10.1093/cid/cit715. Epub 2013 Oct 30. Clin Infect Dis. 2014. PMID: 24178246 Free PMC article.

2

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.

Aitken ML, Moss RB, Waltz DA, Dovey ME, Tonelli MR, McNamara SC, Gibson RL, Ramsey BW, Carter BJ, Reynolds TC. Aitken ML, et al. Among authors: mcnamara sc. Hum Gene Ther. 2001 Oct 10;12(15):1907-16. doi: 10.1089/104303401753153956. Hum Gene Ther. 2001. PMID: 11589832 Clinical Trial.

3

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Emerson J, et al. Among authors: mcnamara s. Pediatr Pulmonol. 2002 Aug;34(2):91-100. doi: 10.1002/ppul.10127. Pediatr Pulmonol. 2002. PMID: 12112774

4

Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.

Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Wilmott R, Zeitlin PL, Ramsey B; Cystic Fibrosis Therapeutics Development Network Study Group. Gibson RL, et al. Among authors: mcnamara s. Am J Respir Crit Care Med. 2003 Mar 15;167(6):841-9. doi: 10.1164/rccm.200208-855OC. Epub 2002 Dec 12. Am J Respir Crit Care Med. 2003. PMID: 12480612 Clinical Trial.

5

Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.

Halbert CL, Miller AD, McNamara S, Emerson J, Gibson RL, Ramsey B, Aitken ML. Halbert CL, et al. Among authors: mcnamara s. Hum Gene Ther. 2006 Apr;17(4):440-7. doi: 10.1089/hum.2006.17.440. Hum Gene Ther. 2006. PMID: 16610931 Free PMC article.

6

Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa.

Hoffman LR, Déziel E, D'Argenio DA, Lépine F, Emerson J, McNamara S, Gibson RL, Ramsey BW, Miller SI. Hoffman LR, et al. Among authors: mcnamara s. Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19890-5. doi: 10.1073/pnas.0606756104. Epub 2006 Dec 15. Proc Natl Acad Sci U S A. 2006. PMID: 17172450 Free PMC article.

7

Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis.

Gibson RL, Emerson J, Mayer-Hamblett N, Burns JL, McNamara S, Accurso FJ, Konstan MW, Chatfield BA, Retsch-Bogart G, Waltz DA, Acton J, Zeitlin P, Hiatt P, Moss R, Williams J, Ramsey BW. Gibson RL, et al. Among authors: mcnamara s. Pediatr Pulmonol. 2007 Jul;42(7):610-23. doi: 10.1002/ppul.20625. Pediatr Pulmonol. 2007. PMID: 17534969

8

Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, Ramsey BW; Inhaled Tobramycin in Young Children Study Group; Cystic Fibrosis Foundation Therapeutics Development Network. Sagel SD, et al. Among authors: mcnamara s. J Pediatr. 2009 Feb;154(2):183-8. doi: 10.1016/j.jpeds.2008.08.001. Epub 2008 Sep 25. J Pediatr. 2009. PMID: 18822427 Free PMC article.

9

Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.

Rosenfeld M, Emerson J, McNamara S, Joubran K, Retsch-Bogart G, Graff GR, Gutierrez HH, Kanga JF, Lahiri T, Noyes B, Ramsey B, Ren CL, Schechter M, Morgan W, Gibson RL; EPIC Study Group Participating Clinical Sites. Rosenfeld M, et al. Among authors: mcnamara s. Pediatr Pulmonol. 2010 Sep;45(9):934-44. doi: 10.1002/ppul.21279. Pediatr Pulmonol. 2010. PMID: 20597081

10

Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.

Mayer-Hamblett N, Kronmal RA, Gibson RL, Rosenfeld M, Retsch-Bogart G, Treggiari MM, Burns JL, Khan U, Ramsey BW; EPIC Investigators. Mayer-Hamblett N, et al. Pediatr Pulmonol. 2012 Feb;47(2):125-34. doi: 10.1002/ppul.21525. Epub 2011 Aug 9. Pediatr Pulmonol. 2012. PMID: 21830317 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters